查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1556601

免疫测量(RIA) 市场报告：2030 年趋势、预测与竞争分析

Radioimmunoassay (RIA) Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

免疫测量(RIA) 趋势与预测

2024年至2030年，全球免疫测量（免疫检测）市场预计将以3.2%的复合年增长率成长。该市场的主要驱动力是癌症发病率的增加、医疗保健自动化需求的不断增长以及医学研究的进步。全球免疫测量(RIA) 市场的未来看起来充满希望，医院、製药、学术和临床诊断实验室市场都充满机会。

免疫测量（RIA）细分市场预测

本研究包括按类型、应用、最终用途和区域对全球免疫测量(RIA) 进行预测。

免疫测量(RIA) 市场洞察

Lucintel 预计试剂和套件在预测期内将出现高速成长。

在这个市场中，临床实验室最受欢迎，因为该设施中免疫测量的利用率很高，因为它们能够以高通量、高灵敏度和高特异性分析生物样本中的各种分析物，预计会出现高成长。

由于有利的报销政策和强大的医疗保健系统的存在，北美在预测期内可能仍然是最大的地区。

常问问题

Q1.市场成长预测是多少：

A1. 2024 年至 2030 年，全球免疫测量(RIA) 市场预计将以 3.2% 的复合年增长率成长。

Q2. 影响市场成长的关键驱动因素是：

A2. 该市场的主要驱动力是癌症发生率的增加、医疗保健自动化需求的增长以及医学研究的进步。

Q3.市场的主要细分市场是：

A3.免疫测量(RIA) 市场的未来前景广阔，在医院、製药、学术和临床实验室市场都有机会。

Q4.市场的主要企业是：

A4.免疫测量（RIA）的主要企业如下：

  • DiaSource ImmunoAssays
  • Beckman Coulter
  • IBL International
  • PerkinElmer
  • DRG International
  • MP Biomedicals
  • Cisbio
  • Euro Diagnostica
  • DiaSorin
  • EMD Millipore

Q5.未来最大的细分市场是什么？

A5.Lucintel 预计试剂和套件在预测期内将出现高速成长。

Q6.未来五年预计哪些地区的市场成长最大？

A6. 由于有利的报销政策和强大的医疗保健系统的存在，北美在预测期内将继续成为最大的地区。

Q7. 可以客製化报告吗？

A7。

目录

第一章执行摘要

第二章全球免疫测量（RIA）市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球免疫测量（RIA）市场趋势（2018-2023）与预测（2024-2030）
  • 全球免疫测量(RIA) 市场（按类型）
    • 试剂/套件
    • 分析仪
  • 全球免疫测量（RIA）市场（按应用）
    • 临床诊断
    • 研究
  • 按最终用途分類的全球免疫测量(RIA) 市场
    • 医院
    • 製药
    • 学术的
    • 临床实验室
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球免疫测量(RIA) 市场：按地区
  • 北美免疫测量（RIA）市场
  • 欧洲免疫测量（RIA）市场
  • 亚太地区放射免疫测量（RIA）市场
  • 其他地区免疫测量（RIA）市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球免疫测量(RIA) 市场的成长机会（按类型）
    • 全球免疫测量(RIA) 市场成长机会（按应用）
    • 按最终用途分類的全球免疫测量(RIA) 市场成长机会
    • 按地区分類的全球免疫测量(RIA) 市场成长机会
  • 全球免疫测量(RIA) 市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球免疫测量(RIA) 市场的产能扩张
    • 全球免疫测量(RIA) 市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • DiaSource ImmunoAssays
  • Beckman Coulter
  • IBL International
  • PerkinElmer
  • DRG International
  • MP Biomedicals
  • Cisbio
  • Euro Diagnostica
  • DiaSorin
  • EMD Millipore
简介目录

Radioimmunoassay (RIA) Trends and Forecast

The future of the global radioimmunoassay (RIA) market looks promising with opportunities in the hospital, pharmaceutical, academic, and clinical diagnostic laboratory markets. The global radioimmunoassay (RIA) market is expected to grow with a CAGR of 3.2% from 2024 to 2030. The major drivers for this market are increasing rates of cancer incidence, growing need for automation in healthcare, and rising advancement in medical research.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Radioimmunoassay (RIA) by Segment

The study includes a forecast for the global radioimmunoassay (RIA) by type, application, end use, and region.

Radioimmunoassay (RIA) Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Reagents & Kits
  • Analyzers

Radioimmunoassay (RIA) Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Clinical Diagnostics
  • Research

Radioimmunoassay (RIA) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Pharmaceuticals
  • Academics
  • Clinical Diagnostic Laboratories
  • Others

Radioimmunoassay (RIA) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Radioimmunoassay (RIA) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies radioimmunoassay (RIA) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the radioimmunoassay (RIA) companies profiled in this report include-

  • DiaSource ImmunoAssays
  • Beckman Coulter
  • IBL International
  • PerkinElmer
  • DRG International
  • MP Biomedicals
  • Cisbio
  • Euro Diagnostica
  • DiaSorin
  • EMD Millipore

Radioimmunoassay (RIA) Market Insights

Lucintel forecasts that reagent & kit is expected to witness higher growth over the forecast period.

Within this market, clinical diagnostic laboratory is expected to witness the highest growth due to substantial usage of radioimmunoassay in this facility given to their ability to analyze a broad variety of analytes in biological samples with high throughput, high sensitivity, and specificity.

North America will remain the largest region over the forecast period due to availability of favorable reimbursement policy and existence of robust healthcare system in the region.

Features of the Global Radioimmunoassay (RIA) Market

Market Size Estimates: Radioimmunoassay (RIA) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Radioimmunoassay (RIA) market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Radioimmunoassay (RIA) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the radioimmunoassay (RIA) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the radioimmunoassay (RIA) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for radioimmunoassay (RIA) market?

Answer: The global radioimmunoassay (RIA) market is expected to grow with a CAGR of 3.2% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the radioimmunoassay (RIA) market?

Answer: The major drivers for this market are increasing rates of cancer incidence, growing need for automation in healthcare, and rising advancement in medical research.

Q3. What are the major segments for radioimmunoassay (RIA) market?

Answer: The future of the radioimmunoassay (RIA) market looks promising with opportunities in the hospital, pharmaceutical, academic, and clinical diagnostic laboratory markets.

Q4. Who are the key radioimmunoassay (RIA) market companies?

Answer: Some of the key radioimmunoassay (RIA) companies are as follows:

  • DiaSource ImmunoAssays
  • Beckman Coulter
  • IBL International
  • PerkinElmer
  • DRG International
  • MP Biomedicals
  • Cisbio
  • Euro Diagnostica
  • DiaSorin
  • EMD Millipore

Q5. Which radioimmunoassay (RIA) market segment will be the largest in future?

Answer: Lucintel forecasts that reagent & kit is expected to witness higher growth over the forecast period.

Q6. In radioimmunoassay (RIA) market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to availability of favorable reimbursement policy and existence of robust healthcare system in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the radioimmunoassay (RIA) market by type (reagents & kits and analyzers), application (clinical diagnostics and research), end use (hospitals, pharmaceuticals, academics, clinical diagnostic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Radioimmunoassay (RIA) Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Radioimmunoassay (RIA) Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Radioimmunoassay (RIA) Market by Type
    • 3.3.1: Reagents & Kits
    • 3.3.2: Analyzers
  • 3.4: Global Radioimmunoassay (RIA) Market by Application
    • 3.4.1: Clinical Diagnostics
    • 3.4.2: Research
  • 3.5: Global Radioimmunoassay (RIA) Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Pharmaceuticals
    • 3.5.3: Academics
    • 3.5.4: Clinical Diagnostic Laboratories
    • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Radioimmunoassay (RIA) Market by Region
  • 4.2: North American Radioimmunoassay (RIA) Market
    • 4.2.1: North American Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
    • 4.2.2: North American Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
  • 4.3: European Radioimmunoassay (RIA) Market
    • 4.3.1: European Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
    • 4.3.2: European Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
  • 4.4: APAC Radioimmunoassay (RIA) Market
    • 4.4.1: APAC Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
    • 4.4.2: APAC Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
  • 4.5: ROW Radioimmunoassay (RIA) Market
    • 4.5.1: ROW Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
    • 4.5.2: ROW Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Type
    • 6.1.2: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Application
    • 6.1.3: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by End Use
    • 6.1.4: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Region
  • 6.2: Emerging Trends in the Global Radioimmunoassay (RIA) Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Radioimmunoassay (RIA) Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Radioimmunoassay (RIA) Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: DiaSource ImmunoAssays
  • 7.2: Beckman Coulter
  • 7.3: IBL International
  • 7.4: PerkinElmer
  • 7.5: DRG International
  • 7.6: MP Biomedicals
  • 7.7: Cisbio
  • 7.8: Euro Diagnostica
  • 7.9: DiaSorin
  • 7.10: EMD Millipore